PMID- 12493510
OWN - NLM
STAT- MEDLINE
DCOM- 20030320
LR  - 20191210
IS  - 1010-7940 (Print)
IS  - 1010-7940 (Linking)
VI  - 23
IP  - 1
DP  - 2003 Jan
TI  - Sorin Bicarbon bileaflet valve: a 10-year experience.
PG  - 86-92
AB  - OBJECTIVE: To present a large 10 year experience of a collaborative evaluation of 
      the Sorin Bicarbon (SB) mechanical prosthesis carried out in 14 centers in eight 
      Western European countries. METHODS: Between 4/90 and 12/96, 2078 SB valves were 
      implanted in 1875 patients aged 4-84 years (mean 58), 1108 males and 767 females. 
      The valves inserted were 1026 aortic valve replacement (AVR), 656 mitral valve 
      replacement (MVR) and 203 double valve replacement (DVR), additional procedures 
      performed in 467 patients (282 coronary artery bypass grafting). RESULTS: Early 
      mortality was 97 (5%), overall survival at 8 years was 71.8% AVR, 69.4% MVR, 
      81.4% DVR. Total late valve-related deaths were 55; overall freedom from 
      valve-related death at 8 years was 95%. New York Heart Association (NYHA) status 
      after surgery: 78% improved and 17% unchanged. Twenty-two valve thrombosis were 
      observed, one fatal; overall freedom from thrombosis at 8 years was 98.5%. 
      Embolism occurred in 95 patients, 77 cerebral events (16 deaths), overall freedom 
      from embolism was 90.7% at 8 years. Six hemolytic events and 26 non-structural 
      dysfunction (all periprosthetic leaks) were reported. Major bleeding occurred in 
      66, with mortality rate of 32% mainly when intracerebral. Overall freedom from 
      bleeding was 90.8% at 8 years. Endocarditis occurred in 31 patients, 29% were 
      fatal; overall freedom from endocarditis was 97.8% at 8 years. Reoperation was 
      performed in 49 cases--periprosthetic leak 20, infective endocarditis 14, 
      thrombosed valve 13 (and non-valve related-2). Mortality (early and late) 
      occurred in three reoperated patients. CONCLUSIONS: This is a durable and 
      effective mechanical valve substitute with low morbidity and mortality and good 
      functional results.
FAU - Borman, J B
AU  - Borman JB
AD  - Hadassah University Hospital, Cardiac Surgery Research Center, P.O. Box 12000, 
      Jerusalem 91120, Israel. jbborman@netvision.net.il
FAU - De Riberolles, C
AU  - De Riberolles C
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PT  - Multicenter Study
PL  - Germany
TA  - Eur J Cardiothorac Surg
JT  - European journal of cardio-thoracic surgery : official journal of the European 
      Association for Cardio-thoracic Surgery
JID - 8804069
SB  - IM
EIN - Eur J Cardiothorac Surg. 2003 May;28(5):853
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - *Aortic Valve
MH  - Chi-Square Distribution
MH  - Child
MH  - Child, Preschool
MH  - Equipment Design
MH  - Female
MH  - Follow-Up Studies
MH  - Heart Valve Diseases/mortality/*surgery
MH  - *Heart Valve Prosthesis
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - *Mitral Valve
MH  - Postoperative Complications
MH  - Reoperation
MH  - Survival Rate
EDAT- 2002/12/21 04:00
MHDA- 2003/03/21 04:00
CRDT- 2002/12/21 04:00
PHST- 2002/12/21 04:00 [pubmed]
PHST- 2003/03/21 04:00 [medline]
PHST- 2002/12/21 04:00 [entrez]
AID - S1010794002006589 [pii]
AID - 10.1016/s1010-7940(02)00658-9 [doi]
PST - ppublish
SO  - Eur J Cardiothorac Surg. 2003 Jan;23(1):86-92. doi: 
      10.1016/s1010-7940(02)00658-9.